flt3L in Treating Patients With Acute Myeloid Leukemia

Completed · Phase 3

Conditions studied: Leukemia

In brief

RATIONALE: Drugs such as flt3L may stimulate a person's immune system and help kill cancer cells. It is not yet known if flt3L is effective in treating acute myeloid leukemia. PURPOSE: Randomized phase III trial to determine the effectiveness of flt3L in treating patients who have acute myeloid leukemia that is in remission.

Key facts

Study ID
NCT00006223
Run by
Eastern Cooperative Oncology Group
Starts
2000-07-01
Expected to finish
2007-01-01
Last updated by the study team
2013-06-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.